Summary

Investigating the Phagocytosis of Leishmania using Confocal Microscopy

Published: July 29, 2021
doi:

Summary

The mechanism associated with phagocytosis in Leishmania infection remains poorly understood. Here, we describe methods to evaluate the early events occurring during Leishmania interaction with the host cells.

Abstract

Phagocytosis is an orchestrated process that involves distinct steps: recognition, binding, and internalization. Professional phagocytes take up Leishmania parasites by phagocytosis, consisting of recognizing ligands on parasite surfaces by multiple host cell receptors. Binding of Leishmania to macrophage membranes occurs through complement receptor type 1 (CR1) and complement receptor type 3 (CR3) and Pattern Recognition Receptors. Lipophosphoglycan (LPG) and 63 kDa glycoprotein (gp63) are the main ligands involved in macrophage-Leishmania interactions. Following the initial recognition of parasite ligands by host cell receptors, parasites become internalized, survive, and multiply within parasitophorous vacuoles. The maturation process of Leishmania-induced vacuoles involves the acquisition of molecules from intracellular vesicles, including monomeric G protein Rab 5 and Rab 7, lysosomal associated membrane protein 1 (LAMP-1), lysosomal associated membrane protein 2 (LAMP-2), and microtubule-associated protein 1A/1B-light chain 3 (LC3).

Here, we describe methods to evaluate the early events occurring during Leishmania interaction with the host cells using confocal microscopy, including (i) binding (ii) internalization, and (iii) phagosome maturation. By adding to the body of knowledge surrounding these determinants of infection outcome, we hope to improve the understanding of the pathogenesis of Leishmania infection and support the eventual search for novel chemotherapeutic targets.

Introduction

Leishmaniasis is a neglected tropical disease caused by protozoan parasites of the genus Leishmania, resulting in a broad spectrum of clinical manifestations in the vertebrate host, including cutaneous leishmaniasis, mucocutaneous leishmaniasis and visceral leishmaniasis1. The World Health Organization (WHO) estimates that over one billion people are at risk, with more than one million new cases reported per year2.

Leishmania spp. are obligate intracellular protozoans that survive inside host cells, including monocytes, macrophages and dendritic cells3. Leishmania-macrophage interaction is a complex process that involves multiple host cell receptors and parasite ligands either through direct interaction or by opsonization involving complement receptors4,5. Classical surface receptors, such as CR1, CR3, mannose-fucose, fibronectin, toll-like and scavenger receptors, mediate parasite attachment to macrophages6,7,8. These receptors recognize molecules on the surface of Leishmania, including the 63 kDa glycoprotein (gp63) and glycolipid lipophosphoglycan (LPG)9. These are the most abundant molecules on the surface of promastigotes and play an essential role in the subversion of host immune response, favoring the establishment of parasite infection in mammalian cells10. After parasite surface ligands bind to macrophage receptors, F-actin accumulates on mammalian cell surfaces, surrounding parasites as they are phagocytosed. Subsequently, this leads to the formation of a parasite-induced compartment termed parasitophorous vacuole (PV), which presents phagolysosomal features11. Once inside these phagolysosomes, parasites undergo several alterations essential to survival and multiplication3.

The biogenesis of PVs is a highly regulated membrane trafficking process critical to the intracellular survival of this pathogen12. The formation of this compartment results from sequential fusion events between phagosomes and compartments of the host endocytic pathway. Classical cell biology studies have revealed that the maturation of PVs involves the acquisition of monomeric G protein Rab 5 and Rab 7 proteins, which are mainly associated with early and late endosome maturation, respectively13. In addition, these compartments acquire lysosome-associated membrane proteins 1 and 2 (LAMP 1, LAMP 2), the principal protein constituents of the lysosomal membrane and microtubule-associated protein 1A/1B-light chain 3 (LC3), an autophagosome marker14. Despite apparent similarities, the kinetics of PV formation15,16 and the morphology of these compartments vary depending on Leishmania species. For example, infection caused by L. mexicana or L. amazonensis induces the formation of large compartments containing a great number of parasites17. By contrast, other species, such as L. braziliensis and L. infantum, form smaller vacuoles that normally contain only one or two parasites in each vacuole18.

Despite this knowledge surrounding host cell-Leishmania interaction, the initial events triggered by contact between host receptors and parasite ligands have not been fully elucidated. These events are known to be determinants of the outcome of parasite infection and are dependent on parasite species, the type of host cell receptors recruited to recognize parasites and the activation of macrophage signaling pathways19,20. Therefore, it is essential to identify the molecules involved in the biogenesis of Leishmania-induced PVs and determine the role(s) played by these molecules in infection establishment and outcome. Here, we describe a method of monitoring early events occurring during the phagocytosis of Leishmania, including binding, internalization, phagosome formation and maturation. This work could aid in clarifying the participation of PLC, Akt, Rab5, Rab7 and LC3 in the formation of PVs induced by different Leishmania species. Importantly, this protocol can be used to investigate the participation of other proteins involved in PV maturation. Future studies will expand the knowledge surrounding mechanisms involved in Leishmania-host cell interaction and contribute to the design of novel chemotherapeutic strategies.

Protocol

Cells were obtained from healthy donors following the approval of procedures by the National Research Ethics Committees (ID: 94648218.8.0000.0040).

1. Cell cultures

  1. Human monocyte-derived macrophages
    NOTE: To obtain human monocyte-derived macrophages for in vitro differentiation into macrophages, collect blood from healthy donors and purify peripheral blood mononuclear cells (PBMC) as described by D. English and B. R. Andersen21.
    1. After collecting peripheral blood (50 mL), pour it into a heparinized tube and then dilute the blood 1:1 in a phosphate buffer solution (PBS) at room temperature. Gently place diluted heparinized blood on top of previously distributed density gradient medium.
    2. Centrifuge the tubes at 252 × g for 30 min at 24 °C to avoid hemolysis.
      NOTE: Set centrifuge break-off to avoid mixing of gradient layers. After centrifugation, discontinuous gradient layers are formed from the bottom to the top: erythrocytes, density gradient medium, PBMC ring and plasma.
    3. Transfer the PBMC ring, located between the density gradient medium and plasma layers, to a new tube and fill with PBS to wash out excess density gradient medium.
    4. Wash cells once and centrifuge at 190 × g for 10 min at 4 °C.
    5. Discard the supernatant and resuspend pellet in 1 mL of complete RPMI medium.
    6. Count the cells and plate 2 × 106 cells in 500 mL of Roswell Park Memorial Institute (RPMI) supplemented with 25 mM N-[2-hydroxyethyl] piperazine-N′-[2-ethane sulfonic acid] (HEPES), 2 g/L sodium bicarbonate, 2 mM glutamine, 20 g/mL ciprofloxacin and 10% inactivated Fetal Bovine Serum (FBS) (complete RPMI medium) for 7 days at 37 °C under 5% CO2 in a 24-well plate to allow monocytes to differentiate into macrophages by adhesion.
  2. THP-1 cultures
    1. Grow THP-1 cell line at a concentration of 2 × 105 cells in 10 mL of complete RPMI medium in 75 cm2 culture flask.
    2. Maintain cell cultures in an incubator at 37 °C under 5% CO2 for 7 days.
    3. Centrifuge cells at 720 × g for 10 min at 4 °C and resuspend the pellet in complete RPMI medium.
    4. Count cells in a Neubauer chamber.
    5. Plate cells on 13 mm glass coverslips at a concentration of 2 × 105 cells per well in 500 μL of complete RPMI medium containing 100 nM phorbol myristate acetate (PMA) at 37 °C under 5% CO2 to allow differentiation of THP1 cells into macrophages.
    6. After three days, wash twice cells with 0.9% NaCl solution to remove medium containing PMA.
    7. Incubate differentiated THP-1 cells in PMA-free complete RPMI medium at 37 °C under 5% CO2 for an additional 2 days before starting experimentation.

2. Parasite cultures and CellTracker Red staining

NOTE: To visualize parasites through fluorescence microscopy, perform staining using CellTracker Red fluorescent dye (CMTPX). Alternatively, other markers, including carboxyfluorescein can be used in accordance with manufacturer instructions or promastigotes constitutively expressing GFP, RFP, or other fluorescent reporter genes. Parasites used to infect cells are those at stationary phase of growth obtained from a promastigote axenic culture of no more than 7 passages.

  1. Grow Leishmania spp. promastigotes at 1 x 105 parasites per 1,000 μL of medium in a cell culture flask containing 5 mL of Schneider's medium supplemented with 50 μg/mL gentamicin and 10% FBS.
  2. After incubating parasite axenic cultures in a biochemical oxygen demand (B.O.D.) at 24 °C, perform daily counting in a Neubauer chamber. Check for parasite form (thin, elongated) and mobility for 5 days. Parasites are considered in stationary phase of growth when two consecutive counts with 8 hours of interval display similar amounts.
  3. Upon reaching the stationary phase of growth, incubate the parasites in 4 mL of 0.9% NaCl solution with 1 μM CMTPX for 15 min at 37 °C under 5% CO2 avoiding contact with light.
  4. Add FBS at a 1:1 proportion and incubate parasite suspension for an additional 1 min.
  5. Wash parasites thrice with PBS, followed by centrifugation at 1,781 × g for 10 min.
  6. Ressuspend parasite pellet in 1,000 μL of RPMI complete medium.
  7. Count parasites in a Neubauer chamber.

3. Assessment of Leishmania binding to macrophages

  1. Seed 2 × 105 THP-1 cells or human monocyte-derived macrophages in 500 μL of complete RPMI medium per well on a 24-well plate with 13 mm glass coverslips.
  2. Cultivate cells at 37 °C under 5% CO2 for 24 h.
  3. Wash the cells twice with 0.9% NaCl solution and incubate in complete RPMI medium at 4 °C for 10 min.
  4. Add stationary phase promastigotes as described by A. L. Petersen22 at a 10:1 ratio to well plates, and then centrifuge at 720 × g for 5 min under 4 °C.
  5. Incubate at 4 °C for 5 min.
  6. Wash the cells twice with 0.9% NaCl solution to remove any non-internalized promastigotes.
  7. Fix the cells in 4% paraformaldehyde for 15 min at room temperature.
  8. Incubate the coverslips with 15 mM NH4Cl for 15 min at room temperature.
  9. Wash thrice with PBS 0.15% bovine serum albumin (BSA). Incubate with blocking solution (3% BSA in PBS) for 1 h at room temperature.
  10. Wash thrice with PBS and then permeabilize with 0.15% PBS-Saponin for 15 min at room temperature.
  11. Add phalloidin (diluted 1:1,200) for 1 h at room temperature and protect from light.
  12. Mount coverslips using mounting media.
  13. Acquire images via a confocal fluorescence microscope using a 63×/1.4 objective.

4. Assessment of Leishmania phagocytosis by macrophages

  1. Seed 2 × 105 THP-1 cells or human monocyte-derived macrophages in 500 μL of complete RPMI medium per well on a 24-well plate with 13 mm glass coverslips.
  2. Cultivate cells for 24 h at 37 °C under 5% CO2.
  3. Wash cells twice in 0.9% NaCl solution and incubate in complete RPMI medium in 24-well plate at 4 °C for 10 min.
  4. Add stationary phase Leishmania spp. as described by A. L. Petersen22 at a 10:1 (parasite:host cell) ratio, and then centrifuge at 720 × g for 10 min under 4 °C.
  5. Incubate cells at 4 °C for 5 min.
  6. Wash the cells twice with 0.9% NaCl solution to remove any non-internalized promastigotes.
  7. Incubate the cells in supplemented RPMI medium at 37 °C for 1 h.
  8. Fix the cells with 4% paraformaldehyde for 15 min.
  9. Mount coverslips using preferred mounting media.
  10. Count no less than 400 cells in random fields under a fluorescence microscope using a 100×/1.4 objective.

5. Evaluation of Leishmania -induced vacuole maturation

NOTE: THP-1 cell transfection should be performed as described by M. B. Maess, B. Wittig and S. Lorkowski 23. Here we summarize this protocol, with minimal modifications. Nucleofection is a specific transfection method that requires a nucleofector. As an alternative method, cells can be transfected using lipofectamine24 and lentivirus transduction25.

  1. To investigate the biogenesis of Leishmania-induced PV, transfect THP1 cells with PLC26,27, Akt26,27, Rab 528,29,30 or Rab 728,29,31 plasmids.
    ​NOTE: This methodology can be used to transfect THP-1 cells with other genes than those listed above.
  2. Seed THP-1 cells at 1.5 x 107 in 75 cm² tissue culture flasks containing 10 mL complete RPMI medium supplemented with 100 ng/mL PMA and 50 µM 2-mercaptoethanol for 48 h.
  3. Wash cells once in 0.9% NaCl solution.
  4. Detach cells using a non-enzymatic cell dissociation solution and centrifuge (250 × g) for 5 min at room temperature.
  5. Resuspend THP-1 cells in 1 mL of RPMI medium and perform counts in a Neubauer chamber.
  6. Centrifuge THP-1 cells again at 250 × g for 10 min at room temperature. Discard the supernatant.
  7. Resuspend 2 × 106 cells in 100 µL of Nucleofector solution and incubate with 0.5 µg of the plasmid coding for the protein of interest, tagged with a fluorescent protein.
  8. Transfer the suspension containing THP-1 cells and nucleic acid to the Nucleofector cuvette.
  9. Transfect THP1 cells using Nucleofector Program Y-001.
  10. Recover the transfected cells (2×106) and seed in 500 μL RPMI medium on 24-well plates with 13 mm glass coverslips (4 wells/transfection).
  11. Incubate THP-1 cells in complete RPMI medium at 37 °C for 0.5, 2, 4, 6, 12 and 24 h.
  12. Repeat steps 3.13 and 3.13.

6. Evaluation of the recruitment of LC3 to Leishmania spp. PVs

NOTE: The autophagic membrane marker LC3 can be used to investigate whether phagosomes present autophagic features. LC3 recruitment to Leishmania-induced PVs can be assessed during infection by immunolabelling cells with the anti-LC3 antibody, as previously described by C. Matte32 and B. R. S. Dias33.

  1. Seed 2 × 105 THP-1 cells or human monocyte-derived macrophages in 500 μL complete RPMI medium on a 24-well plate with 13 mm glass coverslips.
  2. Cultivate cells for 24 h at 37 °C under 5% CO2.
  3. Wash cells twice in 0.9% NaCl solution and incubate in complete RPMI medium.
  4. Add stationary phase Leishmania spp. promastigotes as described by A. L. Petersen22 at a 10:1 (parasite: host cells) ratio and centrifuge cells at 720 × g for 5 min under 4 °C.
  5. Incubate at 37 °C for 30 min or 4 h. Then wash twice and fix the cells to evaluate the LC3 recruitment to Leishmania-induced PV membranes at the early stages of infection.
    1. Alternatively, to assess LC3 recruitment to PV membranes at later stages of infection, wash twice another macrophage group at 4 h of infection to remove any non-internalized promastigotes. Incubate infected cells in complete RPMI medium for an additional 12 h and 24 h, to finally wash twice and fix.
      NOTE: Fixed cells can be kept in PBS or 0.9% NaCl solution at 4 °C until labeling.
  6. Simultaneously block and permeabilize the fixed cells in 0.1% Triton X-100, 1% BSA, 20% normal goat serum, 6% non-fat dry milk, and 50% FBS for 20 min at room temperature.
  7. Incubate the cells with anti-LC3 antibody (1: 200) diluted in PBS for 2 h at room temperature.
    NOTE: As a negative control of the immunostaining, a group of cells should be incubated with immunoglobulin G (IgG) from the animal of primary antibody origin in a concentration equivalent to that used for the primary antibody.
  8. Wash the cells thrice with 0.9% NaCl solution at room temperature.
  9. Incubate the cells with AlexaFluor 488-conjugated goat anti-rabbit IgG (1:500) or the preferred fluorescent-dye conjugated secondary antibodies for 1 h at room temperature.
  10. Wash the cells thrice with 0.9% NaCl solution at room temperature.
  11. Mount coverslips using preferred mounting media.
  12. Acquire images via confocal fluorescence microscope using a 63x/1.4 objective.

7. Confocal microscopy acquisition and Fiji quantification

NOTE: Acquiring immunofluorescence images should be performed using a confocal laser scanning microscope. To reach a better resolution, use an oil-immersion 63x objective lens.

  1. Leave the 13 mm glass coverslips at room temperature and protect them from the light at least 30 min before the acquisition.
  2. Clean the coverslips with an absorbent tissue.
  3. Add a drop of immersion oil to the objective and add the slide.
  4. Move the objective up until the oil touches the slide.
  5. Observe and adjust the focus on the microscope and choose the option 63x objective with oil.
  6. Open the Leica program and adjust the lasers in the 488, 552, and 405 wavelengths.
  7. Select the image resolution 1,024 x 1,024.
  8. Click on the Live button, set the Z stack, and press the Begin option. Then, do it again and press the End button. We recommend 20 μm for slice thickness to get confocal images with good resolutions.
  9. Wait for the image acquisition, and then select the option "Maximum Projection" in the Leica tools.
  10. Save the experiment.
  11. Export the lif or tiff format images to a computer and open the FIJI program.
  12. Open the experiment and set the view stack with the hyper stack. Then select open files individually and stitch tiles.
  13. Select the free hands tool in the Fiji toolbar and trace the cell carefully by hand.
  14. Press the Analyze button and measure to visualize the fluorescence intensity.
  15. Repeat this process to each cell per group.
  16. Save the measurements and export them to a spreadsheet editor.
  17. Add this data to a statistical analysis program and do the statistical analysis.

8. Statistical analysis

NOTE: For data analysis and graphics, use a statistical analysis program.

  1. Open the program.
  2. Insert the obtained data and test the normality parameters.
  3. For data with normal distribution, use the Student t-test and for nonparametric tests, Mann-Whitney test.
  4. Consider data with a statistically significant difference when the p-value is less than 0.05.
  5. Prepare graphics representing the data, with central tendency measures (mean or median) and variation measures.

Representative Results

This report aims to evaluate the early events occurring during the phagocytosis of L. braziliensis isolated from patients presenting L. braziliensis-LCL or L. braziliensis-DL form of CL. Using confocal microscopy, we investigated the main events associated with parasites' phagocytosis: binding, internalization, and phagosome maturation. We first evaluated the L. braziliensis-LCL or L. braziliensis-DL binding and phagocytosis by human monocyte-derived macrophages. The data show that both L. braziliensis-LCL and L. braziliensis-DL similarly bind to macrophages (Figure 1). Also, no differences were observed regarding L. braziliensis-LCL and L. braziliensis-DL phagocytosis by host cells (Figure 2). Finally, we compared the recruitment of LC3 to the PVs induced by L. braziliensis-LCL or L. braziliensis-DL in infected cells. After 30 min, 4 and 12 h of infection, we observed similar percentages of LC3 decorated PVs in L. braziliensis-LCL and L. braziliensis-DL-infected macrophages (Figure 3). These representative results showed that L. braziliensis-LCL and L. braziliensis-DL similarly interact with macrophages during binding, phagocytosis, and biogenesis of PVs, concerning the LC3 recruitment.

Microscopic images representing THP-1 cells efficiently transfected with PLC-GFP, Rab5-GFP, Rab7-GFP plasmids are shown in Figure 4.

Figure 1
Figure 1. Evaluation of L. braziliensis-LCL and L. braziliensis-DL binding to human macrophages. Human monocyte-derived macrophages were infected with L. braziliensis-LCL- or L. braziliensis-DL. After 10 min at 4 °C, the binding was assessed by confocal microscopy. (A) Confocal microscopy images of L. braziliensis-LCL or L. braziliensis-DL (labeled with CMTPX, red) binding to macrophages (labeled with phalloidin, green). For confocal microscopy, cell nuclei were labeled with DAPI (blue). Arrows depict Leishmania-macrophage binding. (B) Percentage of Leishmania binding to the macrophages. A total of 30 cells per group were analyzed. Data represent each replicate of one experiment performed in quintuplicate (unpaired t test, p > 0.05). Please click here to view a larger version of this figure.

Figure 2
Figure 2. Evaluation of L. braziliensis-LCL and L. braziliensis-DL phagocytosis by human macrophages. Human monocyte-derived macrophages were incubated with L. braziliensis-LCL or L. braziliensis-DL for 10 min at 4 °C followed by additional 1 h at 37 °C. Cells were then analyzed by fluorescence microscopy by counting a total of 400 cells. (A) Confocal microscopy images of human macrophages infected by L. braziliensis-LCL or L. braziliensis-DL. For confocal microscopy, cell nuclei were labeled with DAPI (blue). Arrows depict Leishmania parasites nuclei.(B) Percentage of Leishmania phagocytosis. Circles represent data from each replicate of one experiment performed in triplicate (unpaired t test, p > 0.05). Please click here to view a larger version of this figure.

Figure 3
Figure 3. Assessment of LC3 recruitment to PVs induced by L. braziliensis-LCL or L. braziliensis-DL in macrophages. Human monocyte-derived macrophages were infected and then stained with anti-LC3 antibody for 30 min, 4 and 12 h. (A) Confocal microscopy images of L. braziliensis-LCL or L. braziliensis-DL-infected macrophages labeled with anti-LC3 followed by the secondary anti-rabbit IgG antibody conjugated to Alexa Fluor 488 (green). For confocal microscopy, cell nuclei were labeled with DAPI (blue); (B) Percentage of L. braziliensis-LCL or L. braziliensis-DL-induced PVs decorated with LC3-II. A total of 30 cells per group were analyzed. The circles correspond to each randomly selected field analyzed (unpaired t test, p > 0.05). Please click here to view a larger version of this figure.

Figure 4
Figure 4. THP-1 cells expressing PLC, Rab5 or Rab7. After differentiating into macrophages, THP-1 cells were subjected to nucleofection with each gene of interest coupled to GFP fluorescent probes: PLC, Rab5 and Rab7. Subsequently, these cells were fixed, had the nucleus stained with DAPI (blue) and were observed under a confocal microscope using a 63x/1.4 objective. Please click here to view a larger version of this figure.

Discussion

Leishmania-macrophage interaction is a complex process and involves several steps that can influence disease development5. To better understand the mechanisms involved in the interaction of unopsonized Leishmania and host cells, we have described a protocol that employs confocal fluorescence microscopy to assess phagocytosis from early to late stages of Leishmania infection. The use of fluorescence techniques involving two or more fluorophores to investigate cell biology mechanisms, including immunolabeling and the expression of fluorescent-labeled proteins, allows us to analyze the location of several proteins, as well as to simultaneously evaluate cell morphology. The advantages offered by these methods make them the best tools to monitor pathogen-host cell interaction34.

To better understand the phagocytic process involving different particles, it is crucial to analyze this highly dynamic process at the molecular level35. Confocal-fluorescence microscopy has been used for decades to this end and has been shown to be an excellent tool for quantifying phagocytosis through the determination of numbers of internalized particles, or the types of proteins known to be involved in early stages of host-pathogen interaction34. The present study proposed the use of confocal microscopy to analyze events occurring during the phagocytosis of L. braziliensis isolated from patients with different clinical forms (LCL and DL). This technique enables us to study cells expressing specific fluorescent proteins, including PLC, Akt, Rab 5, and Rab 7, and subsequently evaluate the participation of these proteins in the phagocytosis of Leishmania isolates to identify elements relevant to different infection outcomes.

The present study employed primary macrophages and THP1 cells to assess L. braziliensis phagocytosis at early stages of infection. The presently described protocol can also be used to study phagocytosis in Leishmania spp. by other phagocytes, including dendritic cells, monocytes, macrophage cell-lines, and neutrophils derived from human peripheral blood. During the parasite internalization process, a dynamic change in F-actin occurs at the cell membrane surface11. We then labeled proteins located in the cell membrane using a specific marker of phagocytosis36, such as fluorescent PLC, which allowed us to observe the binding stage of Leishmania to host cells, as shown in Figure 4. Staining parasites with fluorescent markers, such as CMTPX or CSFE, is also crucial to assess parasite binding to host cells by immunofluorescence. It is worth noting that this assay requires careful execution: i) wash coverslips gently using washing solutions at room temperature (25 °C), otherwise, samples can be damaged; ii) prepare reagent dilutions precisely; and iii) protect the samples from light34.

A confocal microscope configured to the optimal laser excitement wavelength is capable of obtaining a high-quality sample image. Labeled cells can be stored for weeks in the dark at 4 °C or frozen until the time of analysis. The use of confocal microscopy to evaluate phagocytosis is limited by prolonged times of exposure and high intensity laser beams, which can damage samples, and, in some cases, lead to high levels of background detection in images35,37.

In the present study, instead of using live imaging to follow the phagocytosis of Leishmania spp., we performed a kinetic study by fixing cells at several early times of infection (30 min, 4 h, and 12 h). It must be considered that live imaging offers some advantages, such as the potential to analyze the spatial and temporal dynamics of myriad cellular processes, including phagocytosis, and capturing details that are not observable in static images34. However, live imaging requires that cells be healthy throughout the entire experimentation process, including controlling temperature, pH and oxygen conditions in a microscopic chamber. It is important to note that this cannot be reliably performed at several laboratories around the world.

The nucleofection protocol described has demonstrated efficacy in the transfection of THP-1 cells, as previously reported by M. B. Maess, B. Wittig and S. Lorkowski 23. In this process, it is crucial to gently detach cells to avoid cell damage or loss in cell viability. Based on our experience, we recommend using a non-enzymatic cell dissociation solution to detach cells from plates prior to performing transfection. The authors of the original protocol23 state that the main limitations of this procedure are the need for cells to be in suspension during the nucleofection process, and the fact that inadequate detachment can cause stress. Despite these limitations, the protocol does allow for reliable transfection, reaching a 90% successful transfection rate without losing cell viability.

The characterization of PVs using a set of endocytic markers, including PLC, Akt, Rab5, and Rab7, is essential to improving our understanding of Leishmania phagocytosis. Identifying new proteins that participate in PV biogenesis and comprehensively characterizing these compartments can clarify differences in macrophage response during Leishmania spp. infection. The contribution of our results to the body of knowledge surrounding Leishmania infection outcome will undoubtedly advance our understanding of the pathogenesis of Leishmania infection and support the eventual search for novel chemotherapeutic targets. It is worth noting that this technique can also be extended to other types of studies, including infection by bacteria, yeasts or bead engulfment by many types of cells38,39.

Divulgaciones

The authors have nothing to disclose.

Acknowledgements

We thank Gonçalo Moniz Institute, Fiocruz Bahia, Brazil and the department of microscopy for assistance. This work was supported by INOVA-FIOCRUZ number 79700287000, P.S.T.V. holds a grant for productivity in research from CNPq (305235/2019-2). Plasmids were kindly provided by Mauricio Terebiznik, University of Toronto, CA. The authors would like to thank Andris K. Walter for English language revision and manuscript copyediting assistance.

Materials

2-mercaptoethanol Thermo Fisher Scientific 21985023
AlexaFluor 488-conjugated goat anti-rabbit IgG Thermo Fisher Scientific Tem varios no site
anti-LC3 antibody Novus Biologicals NB600-1384
Bovine serum albumin (BSA) Thermo Fisher Scientific X
CellStripper Corning 25-056-CI
CellTracker Red (CMTPX) Dye Thermo Fisher Scientific C34552
Centrífuga Thermo Fisher Scientific
Ciprofloxacin Isofarma X
CO2 incubator Thermo Fisher Scientific X
Confocal fluorescence microscope (Leica SP8) Leica Leica SP8
Fetal Bovine Serum (FBS) Gibco 10270106
Fluorescence microscope (Olympus Lx73) Olympus Olympus Lx73
Gentamicin Gibco 15750045
Glutamine Thermo Fisher Scientific 35050-061
HEPES (N- 2-hydroxyethyl piperazine-N’-2-ethane-sulfonic acid) Gibco X
Histopaque Sigma 10771
M-CSF Peprotech 300-25
NH4Cl Sigma A9434
Normal goat serum Sigma NS02L
Nucleofector 2b Device Lonza AAB-1001
Nucleofector solution Lonza VPA-1007
Paraformaldehyde Sigma 158127
Phalloidin Invitrogen A12379
Phorbol myristate acetate (PMA) Sigma P1585
Phosphate buffer solution (PBS) Thermo Fisher Scientific 10010023
ProLong Gold Antifade kit Life Technologies P36931
Roswell Park Memorial Institute (RPMI) 1640 medium Gibco 11875-093
Saponin Thermo Fisher Scientific X
Schneider's Insect medium Sigma S0146
Sodium bicarbonate Sigma S5761
Sodium pyruvate Sigma S8636
Triton X-100 Sigma X

Referencias

  1. Goto, H., Lauletta Lindoso, J. A. Cutaneous and mucocutaneous leishmaniasis. Infectious Disease Clinics of North America. 26 (2), 293-307 (2012).
  2. World Health Organization. Control of the leishmaniases. World Health Organization Technical Report Series. (949), 1 (2010).
  3. Alexander, J., Russell, D. G. The interaction of Leishmania species with macrophages. Advances in Parasitology. 31, 175-254 (1992).
  4. Mosser, D. M., Rosenthal, L. A. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Seminars in Cell Biology. 4 (5), 315-322 (1993).
  5. Awasthi, A., Mathur, R. K., Saha, B. Immune response to Leishmania infection. Indian Journal of Medical Research. 119 (6), 238-258 (2004).
  6. Blackwell, J. M. Role of macrophage complement and lectin-like receptors in binding Leishmania parasites to host macrophages. Immunology Letters. 11 (3-4), 227-232 (1985).
  7. Mosser, D. M., Edelson, P. J. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. Journal of Immunology. 135 (4), 2785-2789 (1985).
  8. Gough, P. J., Gordon, S. The role of scavenger receptors in the innate immune system. Microbes and Infection. 2 (3), 305-311 (2000).
  9. Russell, D. G., Wilhelm, H. The involvement of the major surface glycoprotein (gp63) of Leishmania promastigotes in attachment to macrophages. Journal of Immunology. 136 (7), 2613-2620 (1986).
  10. Handman, E., Goding, J. W. The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J. 4 (2), 329-336 (1985).
  11. Holm, A., Tejle, K., Magnusson, K. E., Descoteaux, A., Rasmusson, B. Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: correlation with impaired translocation of PKCalpha and defective phagosome maturation. Cellular Microbiology. 3 (7), 439-447 (2001).
  12. Vergne, I., et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 102 (11), 4033-4038 (2005).
  13. Courret, N., Lang, T., Milon, G., Antoine, J. C. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. International Journal for Parasitology. 33 (12), 1373-1383 (2003).
  14. Gutierrez, M. G., et al. Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cellular Microbiology. 7 (7), 981-993 (2005).
  15. Dermine, J. F., Scianimanico, S., Prive, C., Descoteaux, A., Desjardins, M. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cellular Microbiology. 2 (2), 115-126 (2000).
  16. Desjardins, M., Descoteaux, A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. Journal of Experimental Medicine. 185 (12), 2061-2068 (1997).
  17. Antoine, J. C., Prina, E., Lang, T., Courret, N. The biogenesis and properties of the parasitophorous vacuoles that harbour Leishmania in murine macrophages. Trends in Microbiology. 6 (10), 392-401 (1998).
  18. Alexander, J., et al. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection. European Journal of Immunology. 32 (10), 2923-2933 (2002).
  19. Aderem, A., Underhill, D. M. Mechanisms of phagocytosis in macrophages. Annual Review of Immunology. 17, 593-623 (1999).
  20. Olivier, M., Gregory, D. J., Forget, G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clinical Microbiology Reviews. 18 (2), 293-305 (2005).
  21. English, D., Andersen, B. R. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. Journal of Immunology Methods. 5 (3), 249-252 (1974).
  22. Petersen, A. L., et al. 17-AAG kills intracellular Leishmania amazonensis while reducing inflammatory responses in infected macrophages. PLoS One. 7 (11), 49496 (2012).
  23. Maess, M. B., Wittig, B., Lorkowski, S. Highly efficient transfection of human THP-1 macrophages by nucleofection. Journal of Visualized Experiments. (91), e51960 (2014).
  24. Berges, R., et al. End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo. Oncotarget. 5 (24), 12769-12787 (2014).
  25. Franco, L. H., et al. The Ubiquitin Ligase Smurf1 Functions in Selective Autophagy of Mycobacterium tuberculosis and Anti-tuberculous Host Defense. Cell Host & Microbe. 22 (3), 421-423 (2017).
  26. Corbett-Nelson, E. F., Mason, D., Marshall, J. G., Collette, Y., Grinstein, S. Signaling-dependent immobilization of acylated proteins in the inner monolayer of the plasma membrane. Journal of Cell Biology. 174 (2), 255-265 (2006).
  27. Yeung, T., et al. Receptor activation alters inner surface potential during phagocytosis. Science. 313 (5785), 347-351 (2006).
  28. Romano, P. S., Gutierrez, M. G., Beron, W., Rabinovitch, M., Colombo, M. I. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cellular Microbiology. 9 (4), 891-909 (2007).
  29. Vieira, O. V., et al. Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Molecular and Cellular Biology. 23 (7), 2501-2514 (2003).
  30. Roberts, R. L., Barbieri, M. A., Ullrich, J., Stahl, P. D. Dynamics of rab5 activation in endocytosis and phagocytosis. Journal of Leukocyte Biology. 68 (5), 627-632 (2000).
  31. Vitelli, R., et al. Role of the small GTPase Rab7 in the late endocytic pathway. Journal of Biological Chemistry. 272 (7), 4391-4397 (1997).
  32. Matte, C., et al. Leishmania major Promastigotes Evade LC3-Associated Phagocytosis through the Action of GP63. PLoS Pathogens. 12 (6), 1005690 (2016).
  33. Dias, B. R. S., et al. Autophagic Induction Greatly Enhances Leishmania major Intracellular Survival Compared to Leishmania amazonensis in CBA/j-Infected Macrophages. Frontiers in Microbiology. 9, 1890 (2018).
  34. Babcock, G. F. Quantitation of phagocytosis by confocal microscopy. Methods in Enzymology. 307, 319-328 (1999).
  35. Sanderson, M. J., Smith, I., Parker, I., Bootman, M. D. Fluorescence microscopy. Cold Spring Harbor Protocols. 2014 (10), 071795 (2014).
  36. Lennartz, M. R. Phospholipases and phagocytosis: the role of phospholipid-derived second messengers in phagocytosis. International Journal of Biochemistry & Cell Biology. 31 (3-4), 415-430 (1999).
  37. Rashidfarrokhi, A., Richina, V., Tafesse, F. G. Visualizing the Early Stages of Phagocytosis. Journal of Visualized Experiments. (120), e54646 (2017).
  38. Ramarao, N., Meyer, T. F. Helicobacter pylori resists phagocytosis by macrophages: quantitative assessment by confocal microscopy and fluorescence-activated cell sorting. Infection and Immunity. 69 (4), 2604-2611 (2001).
  39. Bain, J., Gow, N. A., Erwig, L. P. Novel insights into host-fungal pathogen interactions derived from live-cell imaging. Seminars in Immunopathology. 37 (2), 131-139 (2015).

Play Video

Citar este artículo
Paixão, A. R., Dias, B. R. S., Palma, L. C., Tavares, N. M., Brodskyn, C. I., de Menezes, J. P. B., Veras, P. S. T. Investigating the Phagocytosis of Leishmania using Confocal Microscopy. J. Vis. Exp. (173), e62459, doi:10.3791/62459 (2021).

View Video